XSpray Pharma AB
SEK59.53
0
+SEK0+0% Tuesday 13:56
Statistics
Day High
59.53
Day Low
59.53
52W High
77.7
52W Low
29.39
Volume
111
Avg. Volume
473
Mkt Cap
-
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
6NovExpected
Expected EPS
-1.43159988755616
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 0GHZ.LSE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Xspray Pharma AB (publ), a pharmaceutical company, develops protein kinase inhibitors for targeted cancer treatments in Sweden. Its product candidates include HyNap-Nilo, HyNap-Sora, and HyNap-Dasa. The company was formerly known as Xspray Microparticles AB and changed its name to Xspray Pharma AB (publ) in 2017. Xspray Pharma AB (publ) was incorporated in 2003 and is headquartered in Solna, Sweden.
Show more...
CEO
Dr. Per Andersson Ph.D.
Employees
23
Country
SE
ISIN
SE0009973563